Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 70,000 shares at $186.19 ($13.1M) on 2015-12-17, disclosed to the SEC on 2015-12-21.
Scheduled sale ($13.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.19 | 12,411 | $2.3M | 17.6% |
| 2 | $186.87 | 19,801 | $3.7M | 28.2% |
| 3 | $188.14 | 16,289 | $3.1M | 23.3% |
| 4 | $188.80 | 17,903 | $3.4M | 25.7% |
| 5 | $189.73 | 3,596 | $682K | 5.2% |
| Total | $187.69 avg | 70,000 |
| $13.1M |
| 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |